Equity Incentive Plan (Tables)

3 Months Ended

Mar. 31, 2021

Schedule of Additional Information on Stock Option Grants And Vesting

The following table summarizes additional information on stock option grants and vesting (in thousands):

	2019 Plan
	Three Months Ended March 31, 2021		Three Months Ended March 31, 2020
Total fair value of stock options granted	$	2,125	$	7,970
Total fair value of options vested		18		-

Schedule of Black Scholes model for the Private Warrants

To estimate the fair value of the Private Warrants as of December 31, 2020, the Company used a Black Scholes closed form model, which is a Level 3 fair value measurement. Significant inputs into the Black Scholes model for the Private Warrants were as follows:

	December 31, 2020
Expected volatility		16.00	%
Expected term (in years)		3.97
Risk free interest rate		1.74	%
Dividend yield		0.00	%
Exercise Price	$	11.50
Fair value of common stock	$	8.05

Stock Based Compensation Expense Included In Consolidated Statements of Comprehensive Loss

Stock-based compensation expense is included in the Company’s Consolidated Statements of Comprehensive Loss within the following line items (in thousands):

	Three Months Ended March 31, 2021		Three Months Ended March 31, 2020
Cost of revenues	$	342	$	355
General and administrative		396		230
Research and development		64		73
Sales and marketing		176		167
Total	$	978	$	825

Restricted Stock Units [Member]

Schedule of RSUs Activity Under 2019 Plan

The following table summarizes the Company’s RSU activity under the 2019 Plan:

Description	RSUs Outstanding
Balance at December 31, 2020		1,290,432
Granted		308,750
Vested		(16,666	)
Forfeited		(51,190	)
Expired		-
Balance at March 31, 2021		1,531,326

2019 Plan [Member]

Schedule of Stock Option Activity Under 2019 Plan

The following table summarizes the Company’s stock option activity under the 2019 Plan:

Description	Options Outstanding			Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (Years)		Aggregate Intrinsic Value (1)
Options Outstanding, December 31, 2020		4,260,753		$	8.46		9.0	$	54
Granted		1,187,500			8.05
Exercised		(4,465	)		8.00
Forfeited		(146,366	)		8.19
Expired		(1,477	)		8.00
Options Outstanding, March 31, 2021		5,295,945		$	8.37		9.1	$	806
Options Vested and Exercisable, March 31, 2021		1,224,595		$	8.22		8.8	$	216
Options Vested and Expected to vest, March 31, 2021		5,295,945		$	8.37		9.1	$	806

(1) Aggregate intrinsic value represents the difference between the estimated fair value of the underlying Common Stock (as defined below) and the exercise price of outstanding in-the-money options.

Schedule of Black Scholes model for the Private Warrants

The following table summarizes the assumptions used in the valuation models to determine the fair value of awards granted to employees and non-employees under the 2019 Plan:

	Three Months Ended March 31, 2021		Three Months Ended March 31, 2020
Expected volatility	44.61%		37.63%
Expected term (in years)		6.00		6.00
Dividend yield	0.00%		0.00%
Risk-free interest rate	0.70%		1.43%